Mannkind (MNKD) Convertible Debt (2010 - 2024)
Mannkind (MNKD) reported Convertible Debt of $36.1 million for Q4 2024, down 84.11% year-over-year from $226.9 million in Q1 2024, and down 84.18% quarter-over-quarter from $227.9 million in Q3 2024.
Mannkind (MNKD) Convertible Debt (2010 - 2024) Analysis & Trends
Mannkind (MNKD) has 15 years of Convertible Debt data on file, last reported at $36.1 million in Q4 2024.
- Convertible Debt for Q4 2024 came in at $36.1 million, down 84.11% year-over-year; the trailing twelve-month figure through Dec 2024 was $36.1 million (down 84.11% YoY), and the FY2024 annual result was $36.1 million, down 84.11% from the prior year.
- Convertible Debt retreated to $36.1 million in Q4 2024 per MNKD's latest filing, from $227.9 million in the prior quarter.
- Over five years, Convertible Debt peaked at $227.9 million in Q3 2024 and troughed at $5.0 million in Q1 2020.
- A 5-year average of $171.9 million and a median of $224.5 million in 2022 frame the typical range for Convertible Debt.
- The sharpest annual moves came in 2021 and 2024: Convertible Debt surged 4378.88% in 2021, then slumped 84.11% in 2024.
- A 5-year view of Convertible Debt shows it stood at $5.0 million in 2020, then surged by 4378.88% to $223.9 million in 2021, then grew by 0.65% to $225.4 million in 2022, then increased by 0.65% to $226.9 million in 2023, then tumbled by 84.11% to $36.1 million in 2024.
- Business Quant data shows MNKD's Convertible Debt at $36.1 million in Q4 2024, $227.9 million in Q3 2024, and $227.6 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Mannkind | 1.21 Bn | 1.08 Bn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 36.05 Mn |
| Sep 30, 2024 | 227.94 Mn |
| Jun 30, 2024 | 227.58 Mn |
| Mar 31, 2024 | 227.21 Mn |
| Dec 31, 2023 | 226.85 Mn |
| Sep 30, 2023 | 226.49 Mn |
| Jun 30, 2023 | 226.12 Mn |
| Mar 31, 2023 | 225.76 Mn |
| Dec 31, 2022 | 225.40 Mn |
| Sep 30, 2022 | 225.03 Mn |
| Jun 30, 2022 | 224.67 Mn |
| Mar 31, 2022 | 224.31 Mn |
| Dec 31, 2021 | 223.94 Mn |
| Sep 30, 2021 | 223.58 Mn |
| Jun 30, 2021 | 223.22 Mn |
| Mar 31, 2021 | 222.86 Mn |
| Dec 31, 2020 | 5.00 Mn |
| Sep 30, 2020 | 5.00 Mn |
| Jun 30, 2020 | 5.00 Mn |
| Mar 31, 2020 | 5.00 Mn |